Ironwood Pharmaceuticals (IRWD) Change in Cash (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Change in Cash data on file, last reported at $5.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 74.83% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $112.0 million (up 957.57% YoY), and the FY2025 full-year result was $126.9 million, up 3629.82% from the prior year.
• Change in Cash slipped to $5.0 million in Q1 2026, from $75.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $84.1 million in Q1 2023 to a low of -$565.5 million in Q2 2023.
• A 5-year average of -$23.6 million and a median of $348000.0 in 2024 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash sank 535.3% in 2023 and soared 21465.8% in 2025, its largest moves.
• Tracing IRWD's Change in Cash over 5 years: stood at $82.0 million in 2022, then sank by 123.54% to -$19.3 million in 2023, then soared by 101.8% to $348000.0 in 2024, then soared by 21465.8% to $75.0 million in 2025, then tumbled by 93.32% to $5.0 million in 2026.
• Business Quant data shows IRWD's Change in Cash at $5.0 million in Q1 2026, $75.0 million in Q4 2025, and $47.6 million in Q3 2025.